13.00
-0.30
(-2.26%)
As of 9:08:59 AM GMT+2. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
11,922
11,689
14,702
17,809
Total Liabilities Net Minority Interest
12,414
4,569
3,007
2,351
Total Equity Gross Minority Interest
-492
7,120
11,695
15,458
Total Capitalization
8,812
9,534
12,555
16,687
Common Stock Equity
-492
7,120
11,695
15,458
Capital Lease Obligations
890
615
542
139
Net Tangible Assets
-3,161
4,996
10,424
14,673
Working Capital
2,745
4,379
9,119
14,699
Invested Capital
9,075
9,855
12,911
17,036
Tangible Book Value
-3,161
4,996
10,424
14,673
Total Debt
10,457
3,350
1,758
1,717
Net Debt
6,498
--
--
--
Share Issued
12,319.47
12,317.47
12,317.47
12,317.47
Ordinary Shares Number
12,319.47
12,317.47
12,317.47
12,317.47
12/31/2020 - 11/23/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIO.DE Biotest Aktiengesellschaft
42.40
0.00%
T5O0.DE bioXXmed AG
0.6420
-18.11%
BIO3.DE Biotest Aktiengesellschaft
29.80
-0.67%
NVV1.DE Novavax, Inc.
7.85
-0.53%
7V0.DE Darwin AG
28.80
0.00%
AYJ.DE Valneva SE
2.8780
-3.75%
9VC.DE Atai Life Sciences N.V.
1.1840
0.00%
VX1.DE Vertex Pharmaceuticals Incorporated
425.40
-2.78%
NP5.DE Newron Pharmaceuticals S.p.A.
6.79
-8.86%
HPHA.DE Heidelberg Pharma AG
2.6500
+1.15%